Skip to main content
TipRanks
Go Ultimate75% OFF

Neumora Therapeutics, Inc. (NMRA) Ownership - Who Owns Neumora Therapeutics, Inc.?

454 Followers

Neumora Therapeutics, Inc. (NMRA) Ownership Overview

  • 22.38% Insiders
  • 4.69% Mutual Funds
  • 20.43% Other Institutional Investors
  • 6.39% ETFs
  • 46.12% Public Companies and Individual Investors

The ownership structure of Neumora Therapeutics, Inc. (NMRA) stock is a mix of institutional, retail, and individual investors. Approximately 31.50% of the company’s stock is owned by Institutional Investors, 22.38% is owned by Insiders, and 46.12% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Aug 20, 2026Aurora Daljit Singh$269,179
Aug 18, 2026Aurora Daljit Singh$430,180
Feb 18, 2026Aurora Daljit Singh$21,886
Feb 18, 2026Joshua Pinto$21,064

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Jun 30, 2026Graham Capital Management, L.p.$81,464
Jun 30, 2026 $13,246,177

Top Shareholders

NMRA top shareholders
Holder# of SharesType% HoldingValue
Kristina Burow33,895,555Insider18.04%14,507,298
BlackRock, Inc.8,140,913Institution4.33%3,484,311
Paul Berns7,794,476Insider4.15%3,336,036
Vanguard5,484,910Institution2.92%2,347,541
Joseph Edelman5,104,097Institution2.72%2,184,554
Ishares4,795,967Institution2.55%2,052,674
Vanguard Index Funds4,561,614Institution2.43%1,952,371
Fidelity Salem Street Trust1,228,645Institution0.65%525,860
Fidelity Concord Street Trust948,933Institution0.51%406,143
Vanguard Scottsdale Funds709,754Institution0.38%303,775

Top Mutual Fund Holders

NMRA top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Index Funds4,561,614Institution2.43%1,952,371
Fidelity Salem Street Trust1,228,645Institution0.65%525,860
Fidelity Concord Street Trust948,933Institution0.51%406,143
Vanguard Scottsdale Funds709,754Institution0.38%303,775
Schwab Capital Trust292,075Institution0.16%125,008
Bridgeway Funds, Inc.225,000Institution0.12%96,300
Vanguard World Fund198,483Institution0.11%84,951
Tiaa-cref Funds157,413Institution0.08%67,373
Goldman Sachs Trust83,427Institution0.04%35,707
Dfa Investment Dimensions Group Inc79,063Institution0.04%33,839

Top ETF Holders

NMRA top ETF holders
Holder# of SharesType% HoldingValue
Vanguard Total Stock Market ETF, VTI ETF3,435,554Institution1.83%2,048,277
iShares Russell 2000 ETF, IWM ETF2,509,886Institution1.34%1,076,490
Vanguard Extended Market ETF, VXF ETF1,126,060Institution0.60%671,357
iShares Russell 2000 Growth ETF, IWO ETF1,066,287Institution0.57%457,330
Vanguard Russell 2000 ETF, VTWO ETF602,624Institution0.32%359,284
iShares Biotechnology ETF, IBB ETF587,380Institution0.31%251,927
Schwab U.S. Small-Cap ETF, SCHA ETF550,315Institution0.29%238,286
iShares Micro-Cap ETF, IWC ETF321,057Institution0.17%137,701
Dimensional U.S. Small Cap ETF, DFAS ETF283,960Institution0.15%122,955
EA Bridgeway Ultra-Small Company Market ETF, BUSM ETF217,517Institution0.12%102,886

FAQ

Who Owns Neumora Therapeutics, Inc. (NMRA)?
According to the latest TipRanks data, approximately 31.50% of the company's stock is held by institutional investors, 22.38% is held by insiders, and 46.12% is held by public companies and individual investors.
What percentage of Neumora Therapeutics, Inc. (NMRA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 31.50% of Neumora Therapeutics, Inc. (NMRA) stock is held by institutional investors: 4.69% by mutual funds, 6.39% by ETFs and 20.43% by other institutional investors.
What percentage of Neumora Therapeutics, Inc. (NMRA) stock is held by retail investors?
According to the latest TipRanks data, approximately 46.12% of Neumora Therapeutics, Inc. (NMRA) stock is held by public companies and individual investors.
Who owns the most shares of Neumora Therapeutics, Inc. (NMRA)?
Kristina Burow owns the most shares of Neumora Therapeutics, Inc. (NMRA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.